The products whose formulas have undergone double-blind placebo-controlled IGF-1 clinical trials to measure effectiveness are listed below.

IGF-1 blood levels are used to measure growth hormone therapy in adults because it reflects whether GH is improving or not. Measuring an actual growth hormone level requires attempted pituitary stimulation using intravenous medications in a hospital setting and blood is drawn every 30 minutes over a period of hours. Such testing is not feasible for an extended clinical trial of a group of patients over a period of months.

PLEASE NOTE: If a brand of product is not listed below it's because that brand has not had any legitimate IGF-1 clinical studies to prove whether it can actually increase growth hormone in the body.

ProBLEN (our Brand)¹

Physician Supervised Clinical Study Results (our clinical studies)

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1- 21	23.2 ng/ml to 49.6 ng/ml	44.09 ng/ml to 114.5 ng/ml	Average +160.6%	5 Months

Overall Average IGF-1 Change: +160.6%
Clinical Studies by Dr. Juan Hernandez Flores, Lic., and Irais Castellanos Mungula, at the Centro Geriatrico Naturista, Mexico D.F.¹ (click here for our clinical study specifics)

Nu-Spring*

Clinical Studies

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1	112 on 12/17/96	206 on 5/27/97	+84%	161 Days
2	73 on 1/14/97	258 on 6/24/97	+253.4%	161 Days
3	123 on 1/22/97	188 on 3/25/97	+52.9%	62 Days
*4	115 on 1/31/97	218 on 5/27/97	+89.6%	116 Days
5	229 on 2/01/97	259 on 4/5/97	+13.1%	63 Days
6	142 on 2/4/97	264 on 5/31/97	+85.9%	116 Days
7	97 on 2/28/97	132 on 4/04/97	+36.1%	35 Days
8	131 on 3/15/97	247 on 5/16/97	+88.6%	62 Days
9-18	no information given for patients 9 - 18

Average Change: +105.8%
(FOD #619-824-3423 #7 - #14) (Total study included 18 people - average is of that total group)

*If you compare the results of Nu-Spring and PRO-Symbio Plus you will notice that it appears they reported some of the same results. For instance, Nu-Spring's patient 4 is identical to PRO-Symbio's patient 2. Perhaps both brands use the same formula.

PRO-Symbio PLUS*

Clinical Studies

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1	106 on 04/18/97	203 on 05/27/97	+91.5%	39 Days
*2	115 on 01/31/97	218 on 05/27/97	+89.6%	116 Days
3	131 on 03/15/97	247 on 05/16/97	+88.6%	62 Days
4	115 on 1/31/97	259 on 04/05/97	+13.1%	63 Days
5	183 on 03/21/97	261 on 05/20/97	+42.6%	60 Days
6	36 on 04/08/97	101 on 05/30/97	+180.6%	52 Days
7	97 on 02/28/97	132 on 04/04/97	+36.1%	35 Days
8	142 on 02/04/97	264 on 05/31/97	+85.9%	116 Days

Overall Average Change: +105.8%
Overall Average Days: 68.6 days

Regenesis 1

Identical to LifeSpan I
Clinical Results

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1	135 on 4/8/97	279 on 9/2/97	+74%	27 Days?
2	141 on 2/25/97	208 on 3/27/97	+34%	29 Days
3	72 on 4/5/97	195 on 6/5/97	+170%	63 Days
4	142 on 4/21/97	172 on 10/30/97	+21%	188 Days
5	176 on 4/10/97	185 on 10/24/97	+5%	192 Days
6	84 on 2/97	168 on 7/22/97	+100%	171 Days
7	167 on 4/10/97	185 on 10/24/97	+11%	192 Days
8	208 on 3/27/97	279 on 9/2/97	+34%	153 Days
9-23	No information given for patients #9 - #23

Average Change: +82.8%
(Total study included 23 people - average is of that total group)

Pro-hGH

Physician Supervised Clinical Studies

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1	93 on 1/31/97	127 on 2/5/97	+37%	6 Days
2	73 on 1/14/97	141 on 2/25/97	+93%	11 Days
3	21 on 1/14/97	69 on 2/5/97	+229%	22 Days
4	110 on 1/18/97	180 on 2/4/97	+64%	18 Days
5	357 on 1/24/97	388 on 1/25/97	+8.5%	1 Day?
6	167 on 1/24/97	178 on 1/25/97	+7%	1 Day?
7	242 on 1/25/97	273 on 1/27/97	+12.5%	1 Day?
8	255 on 1/27/97	269 on 1/29/97	+5.5%	2 Days

Average Change: +57.06%

Rejuvamin

Clinical Study- Complete Results
REJUVAMIN QID 2 GRAMS - SIX WEEK DURATION

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change
1	106	241	+127.4%
2	120	200	+66.7%
3	146	276	+89.0%
4	124	165	+33.1%
5	162	225	+38.9%
6	108	196	+81.5%
7	182	241	+32.4%
8	124	208	+67.7%
9-12	No information given for patients 9 - 12

Average Change: +56.8%
(Total study included 12 people - average is of that total group) Clinical Study carried out by Dr. Timothy Bassett and Dr. Steven Smith at the LiFExtension Institute

Eden GH-1

Clinical Test Studies

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1	167 on 1/13/97	186 on 2/12/97	+11%	31 Days
2	206 on 1/13/97	280 on 2/11/97	+36%	29 Days
3	174 on 1/17/97	185 on 2/20/97	+6%	34 Days
4	201 on 1/17/97	271 on 2/21/97	+35%	35 Days
5	212 on 1/20/97	286 on 2/24/97	+35%	26 Days
6	119 on 1/20/97	159 on 2/24/97	+34%	35 Days
7	142 on 1/20/97	190 on 2/27/97	+31%	38 Days
8	122 on 1/24/97	223 on 4/16/97	+83%	82 Days
9-35	No information given for patients 9 - 35

Average Change: +44.09%
(Total study included 35 people - average is of that total group)

Biogevity

Research Studies- In outcome based research studies performed on 20 subjects supplementing with BioGevity for up to 26 weeks, 75% of subjects (15 people) experienced a 41% average increase in IGF-1 levels (insulin-like growth factor-1, a stable indicator of Somatotropin levels).

Total Increases for 75% of Subjects: +41%
(results of 15 subjects given, results of other 5 subjects not given)

Other Brands

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
None	None	None	None	None

The Specifics of Our ProBLEN IGF-1 Clinical Studies.

Information About Proper IGF-1 Clinical Testing and the False or Misleading Reporting Some Use.

Our Pharmaceutical Lab's Survey of Clients Taking ProBLEN Human Growth Hormone.

Bibliography

1. Dr. Juan Hernandez Flores, Dr. Francisco Butron, Irais Castellanos Mungula, Centro Geriatrico Naturista, Mexico D.F., "The Effects of Homeopathic Human Growth Hormone and Pituitary Extract Administered to 21 Adult and Elderly Subjects Deficient in Growth Hormone," La Homeopatia de Mexico, March-April 2000.